bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 27 2025
0mins
Source: Newsfilter
Tender Offer Reminder: bluebird bio, Inc. urges stockholders to tender their shares in the ongoing offer by Carlyle and SK Capital before the deadline of May 29, 2025, emphasizing the importance of re-tendering shares due to an amended agreement that offers different cash options.
Acquisition Update: Ayrmid Ltd. will not pursue a binding proposal for bluebird, reinforcing the Board's recommendation for stockholders to accept the current transaction with Carlyle and SK Capital, which is viewed as the only viable option to avoid significant financial risks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
